The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

You have been exercising, eating home-cooked meals, and have managed to cut out fried food and desserts from your diet for ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

A father has lost six stone in 11 months by taking Mounjaro, yet he face accusations on social media, saying that he is a 'lazy cheat' and that he is 'taking the easy way out'.

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and ...

Drug major Cipla, led by MD and CEO Umang Vohra, is entering India's weight management segment and strengthening its CNS ...